In a preclinical study, inhibition of FLIP expression with both chemical inhibitors and siRNA increased anoikis and reduced distal tumor formation in a mouse model for circulating prostate cancer metastasis [77], indicating that FLIP inhibition decreases the survival of circulating tumor cells and thereby decreases metastatic tumor formation in distant organs. The gene discussed is CFLAR; the disease is prostate carcinoma.